Nevertheless, the exact molecular impact of SHBG on adipose tissue metabolism, inflammation and insulin resistance remains elusive, and more advanced investigations are needed to clarify the possible use of the glycoprotein as a therapeutic agent for metabolic disorders management. This evidence concerns the gene SHBG and metabolic disease.